Improving the appropriateness of vancomycin use by sequential interventions

American Journal of Infection Control

Volumn 27, Issue 2, 1999, Pages 84-90

  Lipsky, Benjamin A ^a,b   Baker, Catherine A ^a   McDonald, Linda L ^a   Suzuki, Norman T ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA Puget Sound   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL EDUCATION; CLINICAL TRIAL; DRUG MISUSE; ENTEROCOCCUS; FOLLOW UP; HUMAN; INFECTION CONTROL; PERIOPERATIVE PERIOD; PHASE 3 CLINICAL TRIAL; PRACTICE GUIDELINE; PRESCRIPTION; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0032941002     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-6553(99)70086-6     Document Type: Article

References (32)

1. Jarvis WR. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: the complexity of the problem. Infect Control Hosp Epidemiol 1996;17:490-5.
2. Hospital Infection Control Practices Advisory Committee (HICPAC), Centers for Disease Control and Prevention. Preventing the spread of vancomycin resistance: a report from the Hospital Infection Control Practices Advisory Committee prepared by the subcommittee on prevention and control of antimicrobial-resistant microorganisms in hospitals. Infect Control Hosp Epidemiol 1995;16:105-13.
3. Quale J, Landman D, Atwood E, Kreiswirth B, Willey BM, Ditore V, et al. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. AJIC Am J Infect Control 1996;24:372-9.
4. Handwerger S, Raucher B, Altarac D, Monka J, Marchione S, Singh KV, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750-5.
5. Morris JG, Shay DK, Hebden JN, McCarter RJ, Perdue BE, Jarvis W, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann Intern Med 1995;123:250-9.
6. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700-5.
7. Slaughter S, Hayden MK, Nathan C, Hu TC, Rice T, Van Voorhis J, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996;125:448-56.
8. Gordts B, Van Landuyt H, Ieven M, Vandamme P, Goossens H. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol 1995;33:2842-6.
9. Boyce JM. Vancomycin-resistant enterococci: pervasive and persistent pathogens. Infect Control Hosp Epidemiol 1995;16:676-9.
10. Hospital Infection Control Practices Advisory Committee (HICPAC), Centers for Disease Control and Prevention. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR Morb Mortal Wkly Rep 1997;46:626-8,635.
11. Santibanez S, Riley DK, Slifkin M, Chan-Tompkins NH, Babinchak TJ, Rotheram EB. Emergence of vancomycin-resistant enterococci at a large teaching hospital. In: Programs and abstracts of the 34th Annual Meeting of the Infectious Diseases Society of America (abstract 53); September 18-20, 1996; New Orleans, La.
12. Dever LL, China C, Eng RH, O'Donovan C, Johanson WG. Vancomycin-resistant Enterococcus faecium in a Veterans Affairs Medical Center: association with antibiotic usage. AJIC Am J Infect Control 1998;26:40-6.
13. Tornieporth NG, Roberts RB, John J, Hafner A, Riley LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996;23:767-72.
14. Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020-5.
15. Anglim AM, Klym B, Byers KB, Scheld WM, Farr BM. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Arch Intern Med 1997;157:1132-6.
16. Johnson SV, Hoey LL, Vance-Bryan K. Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention. Pharmacotherapy 1995;15:570-85.
17. Rybak MJ, Palmer SM. Vancomycin-resistant enterococci. Pharmacotherapy 1995;15:684-5.
18. Ena J, Dick RW, Jones RN, Wenzel RP. The epidemiology of intravenous vancomycin usage in a university hospital. JAMA 1993;269:598-602.
19. Evans ME, Kortas KJ. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines. Infect Control Hosp Epidemiol 1996;17:356-9.
20. Misan GM, Martin ED, Smith ER, Somogyi AA, Bartholomeusz RC, Bochner F. Drug utilization review in a teaching hospital: experience with vancomycin. Eur J Clin Pharmacol 1990;39:457-61.
21. Nightingale J, Chaffee BW, Colvin CL, Alexander MR, Rice T, Ross MB. Retrospective evaluation of vancomycin use in a university hospital. Am J Health Syst Pharm 1987;44:1807-9.
22. Fletcher CV, Giese RM, Rodman JH. Pharmacist interventions to improve prescribing of vancomycin and tobramycin. Am J Health Syst Pharm 1986;43:2198-201.
23. Logsdon BA, Lee KR, Luedtke G, Barrett FF. Evaluation of vancomycin use in a pediatric teaching hospital based on CDC criteria. Infect Control Hosp Epidemiol 1997;18:780-2.
24. Watanakunakorn C. Prescribing pattern of vancomycin in a community teaching hospital with low prevalence of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1997;18:767-9.
25. Salemi C, Becker L, Morrissey R, Warmington J. A clinical decision process model for evaluating vancomycin use with modified HICPAC guidelines. Clin Perform Qual Health Care 1998;6:12-6.
26. Morgan AS, Brennan PJ, Fishman NO. Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycin-resistant Enterococcus. Ann Pharmacother 1997;31:970-3.
27. Manipulating antibiotic use patterns may lower VRE [editorial]. Hosp Infect Control 1997;24(12):186-7.
28. Belliveau PB, Rothman AL, Maday CE. Limiting vancomycin use to combat vancomycin-resistant Enterococcus faecium. Am J Health Syst Pharm 1996;53:1570-5.
29. Lynch P, Cummings MJ, Roberts PL, Herriott MJ, Yates B, Stamm WE. Implementing and evaluating a system of generic infection precautions: body substance isolation. AJIC Am J Infect Control 1990;18:1-12.
30. Polk R. Vancomycin prescribing in the era of vancomycin-resistant enterococci [editorial], Pharmacotherapy 1995;15:682-3.
31. Reichley RM, Miller JE, Sahm DF, Mundy LM, Fraser VJ, Kwhn MG, et al. Use of an administrative database to estimate vancomycin utilization and appropriateness. In: Programs and abstracts of the 34th Annual Meeting of the Infectious Diseases Society of America (abstract 41); September 18-20, 1996; New Orleans, La.
32. Rai M, Bobek MB, Capozzi D, Lee P, Goldman M, Longworth D, et al. Vancomycin use in a tertiary care referral center, compliance with the CDC recommendations for preventing the spread of vancomycin resistance. In: Programs and abstracts of the 34th Annual Meeting of the Infectious Diseases Society of America (abstract 3); September 18-20, 1996; New Orleans, La.